China National Medicines Corp Ltd (600511) — Tangible Net Worth Ratio
China National Medicines Corp Ltd (600511) has a Tangible Net Worth Ratio of 98.2% as of September 2025. This metric is calculated by deducting intangible assets (CN¥366.68 Million) from net assets (CN¥19.93 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See China National Medicines Corp Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
China National Medicines Corp Ltd Tangible Net Worth Ratio (1999–2024)
This chart shows how China National Medicines Corp Ltd's Tangible Net Worth Ratio has changed across 26 annual periods from 1999 to 2024. As of September 2025, the ratio stands at 98.2%, reflecting net assets of CN¥19.93 Billion with intangible assets of CN¥366.68 Million CNY. See 600511 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for China National Medicines Corp Ltd (1999–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for China National Medicines Corp Ltd from 1999 to 2024, covering 26 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see how much is China National Medicines Corp Ltd worth.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 97.9% | CN¥18.98 Billion | CN¥391.56 Million | CN¥34.93 Billion | ▲ +0.1 pp |
| 2023 | 97.8% | CN¥17.53 Billion | CN¥386.10 Million | CN¥32.45 Billion | ▼ -0.1 pp |
| 2022 | 97.9% | CN¥15.86 Billion | CN¥330.91 Million | CN¥29.61 Billion | ▲ +0.2 pp |
| 2021 | 97.7% | CN¥14.36 Billion | CN¥326.21 Million | CN¥27.48 Billion | ▲ +0.3 pp |
| 2020 | 97.5% | CN¥13.09 Billion | CN¥330.38 Million | CN¥24.90 Billion | ▲ +0.1 pp |
| 2019 | 97.3% | CN¥12.16 Billion | CN¥324.45 Million | CN¥24.19 Billion | ▲ +0.0 pp |
| 2018 | 97.3% | CN¥10.61 Billion | CN¥287.28 Million | CN¥21.51 Billion | ▲ +0.2 pp |
| 2017 | 97.1% | CN¥9.46 Billion | CN¥278.74 Million | CN¥20.17 Billion | ▼ -0.5 pp |
| 2016 | 97.6% | CN¥4.02 Billion | CN¥96.46 Million | CN¥7.40 Billion | ▲ +0.3 pp |
| 2015 | 97.3% | CN¥3.51 Billion | CN¥94.19 Million | CN¥6.56 Billion | ▲ +0.7 pp |
| 2014 | 96.6% | CN¥2.58 Billion | CN¥87.73 Million | CN¥5.54 Billion | ▼ -0.1 pp |
| 2013 | 96.7% | CN¥2.20 Billion | CN¥73.34 Million | CN¥5.08 Billion | ▲ +0.5 pp |
| 2012 | 96.2% | CN¥1.87 Billion | CN¥71.74 Million | CN¥4.56 Billion | ▼ -3.1 pp |
| 2011 | 99.3% | CN¥1.53 Billion | CN¥10.97 Million | CN¥3.55 Billion | ▲ +0.1 pp |
| 2010 | 99.2% | CN¥1.34 Billion | CN¥11.10 Million | CN¥3.39 Billion | ▲ +0.1 pp |
| 2009 | 99.1% | CN¥1.08 Billion | CN¥9.73 Million | CN¥2.78 Billion | ▲ +0.5 pp |
| 2008 | 98.6% | CN¥868.25 Million | CN¥11.91 Million | CN¥2.00 Billion | ▼ -0.7 pp |
| 2007 | 99.3% | CN¥725.96 Million | CN¥5.15 Million | CN¥1.96 Billion | ▲ +0.4 pp |
| 2006 | 98.9% | CN¥590.99 Million | CN¥6.56 Million | CN¥1.36 Billion | ▲ +0.2 pp |
| 2005 | 98.7% | CN¥521.33 Million | CN¥6.63 Million | CN¥1.28 Billion | ▼ -0.6 pp |
| 2004 | 99.3% | CN¥488.38 Million | CN¥3.39 Million | CN¥1.19 Billion | ▼ 0.0 pp |
| 2003 | 99.3% | CN¥468.65 Million | CN¥3.17 Million | CN¥1.09 Billion | ▼ -0.3 pp |
| 2002 | 99.6% | CN¥399.62 Million | CN¥1.56 Million | CN¥808.37 Million | ▼ -0.4 pp |
| 2001 | 100.0% | CN¥134.77 Million | CN¥0.00 | CN¥435.76 Million | ▲ +0.0 pp |
| 2000 | 100.0% | CN¥124.50 Million | CN¥0.00 | CN¥382.83 Million | ▲ +0.0 pp |
| 1999 | 100.0% | CN¥122.05 Million | CN¥47.19K | CN¥570.85 Million | — |